within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M09A_OtherDrugsForDisordersOfTheMusculoSkeletalSystem.M09AB52_TrypsinCombinations;

model TrypsinCombinations
  extends Pharmacolibrary.Drugs.ATC.M.M09AB52;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M09AB52</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Trypsin, in pharmaceutical combinations, is a proteolytic enzyme preparation used to aid in the removal of dead tissue, reduce inflammation, and enhance wound healing. Historically, it has also been used as an adjunct in the treatment of soft tissue injuries and inflammatory conditions. Its clinical use has decreased with the advent of more effective therapies, and it is not a widely approved active pharmaceutical ingredient today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for typical adult subjects, as no published human PK studies with precise parameters for trypsin, combinations (ATC M09AB52), were found.</p><h4>References</h4><ol><li><p>Karamanidou, T, et al., &amp; Kiparissides, C (2015). Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 97(Pt A) 223–229. DOI:<a href=\"https://doi.org/10.1016/j.ejpb.2015.04.013\">10.1016/j.ejpb.2015.04.013</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25933940/\">https://pubmed.ncbi.nlm.nih.gov/25933940</a></p></li><li><p>Burshtein, G, et al., &amp; Schwartz, P (2021). The combined effect of permeation enhancement and proteolysis inhibition on the systemic exposure of orally administrated peptides: Salcaprozate sodium, soybean trypsin inhibitor, and teriparatide study in pigs. <i>International journal of pharmaceutics: X</i> 3 100097–None. DOI:<a href=\"https://doi.org/10.1016/j.ijpx.2021.100097\">10.1016/j.ijpx.2021.100097</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34704013/\">https://pubmed.ncbi.nlm.nih.gov/34704013</a></p></li><li><p>Geĭtman, IIa, et al., &amp; Kivman, GIa (1975). [Comparison of the effect of trypsin and chymotrypsin on the pharmacokinetics of penicillins in the body of rats]. <i>Antibiotiki</i> 20(11) 1019–1023. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1225167/\">https://pubmed.ncbi.nlm.nih.gov/1225167</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end TrypsinCombinations;
